Caricamento...
Mucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteria
BACKGROUND: Mucosal delivery of therapeutic protein drugs or vaccines is actively investigated, in order to improve bioavailability and avoid side effects associated with systemic administration. Orally administered bacteria, engineered to produce anti-inflammatory cytokines (IL-10, IL-1Ra), have sh...
Salvato in:
| Pubblicato in: | BMC Biotechnol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2004
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC534112/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15516267/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1472-6750-4-27 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|